Who
Katherine Stueland
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, GeneDx Holdings; Chief Commercial Officer, Invitae.
In numbers
- Trades disclosed
- 339
- Buys
- 1
- Sells
- 91
- Bought
- $100K
- Sold
- $55.6M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 3 Feb 2017
- Last trade
- 16 Sep 2026
- Last filed
- 18 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Code M | —18,750 at $0.00 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $155K1,648 at $94.26 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $14K148 at $95.41 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —18,750 at $0.00 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $148K1,525 at $96.90 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $407K4,141 at $98.27 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $301K3,039 at $99.00 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —18,750 at $0.00 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Code M | —18,750 at $0.00 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $155K1,648 at $94.26 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $14K148 at $95.41 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $148K1,525 at $96.90 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $407K4,141 at $98.27 | filing |
| 16 Sep 2026filed 18 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $301K3,039 at $99.00 | filing |
| 9 Sep 2026filed 11 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Code M | —6,547 at $0.00 | filing |
| 9 Sep 2026filed 11 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $311K3,692 at $84.22 | filing |
| 9 Sep 2026filed 11 Sep 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —6,547 at $0.00 | filing |
| 9 Sep 2026filed 11 Sep 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —6,547 at $0.00 | filing |
| 9 Sep 2026filed 11 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Code M | —6,547 at $0.00 | filing |
| 9 Sep 2026filed 11 Sep 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $311K3,692 at $84.22 | filing |
News
GeneDx (NASDAQ:WGS) CEO Katherine Stueland Sells 10,501 Shares of Stockdailypolitical.com · 19 Sep 2026
1 headline in the last 90 days name Katherine Stueland; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.